Top Banner
Dr. Bhagbanprakash National AIDS Control Organization Feedback Received from Partners
25
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Feedback received from partners

Dr. Bhagbanprakash

National AIDS Control Organization

Feedback Received from Partners

Page 2: Feedback received from partners

2

Feedback received from partners

WHO (WR) BILL & MELINDA GATES FOUNDATION INP+ CIDA WORLD BANK DFID IAVI EUROPEAN UNION

Page 3: Feedback received from partners

3

Feedback awaited from

UNDP UNICEF UNODC UNFPA UNIFEM ILO UNESCO WFP

Page 4: Feedback received from partners

4

Feedback awaited from

UNHCR USAID CDC AusAID SIDA EMBASSY OF FDR GERMANY ROYAL NORWEGIAN EMBASSY ROYAL NETHERLANDS EMBASSY

Page 5: Feedback received from partners

5

Feedback awaited from

ROYAL NORWEGIAN EMBASSY ROYAL NETHERLANDS

EMBASSY JICA DANIDA

Page 6: Feedback received from partners

6

Partner inputs on key issues (Summary)

Identify and resolve major institutional and capacity issues hindering the scaling up and implementation of the NACP. Effective involvement of different sectors in promoting NACP.Engage UN Theme Group members in programme design; organize regular bilateral consultations.

Page 7: Feedback received from partners

7

Partner inputs on key issues (Summary)

Promote decentralization, strengthen stewardship roles of NACO and SACS.

Generate commitment among different states, stakeholders.

Extend NACP focus on rural areas: integrated geographically focussed programme models.

Page 8: Feedback received from partners

8

Partner inputs on key issues (Summary)

Engage UN Theme Group members in programme design; organize regular bilateral consultations.

Promote decentralization, strengthen stewardship roles of NACO and SACS.

Generate commitment among different states, stakeholders.

Page 9: Feedback received from partners

9

Partner inputs on key issues (Summary)

Extend NACP focus on rural areas: integrated geographically focussed programme models.

Focus on HIV prevention among high-risk behaviour groups, especially female sex workers and their clients.

Empower SACS and their implementing partners.

Engender NACP-III implementation.

Page 10: Feedback received from partners

10

Partner inputs on key issues (Summary)

Service delivery: Create a model package of services for

key populations and bring that suite of services to scale through a variety of partners.

Provide treatment and care in a phased, well-planned and sustainable manner.

Page 11: Feedback received from partners

11

Partner inputs on key issues (Summary)

Include AIDS vaccine as an integral component of preventive strategies. Increased coordination between AIDS vaccine development and sentinel surveillance, VCTC, care and treatment services.Ensure access to affordable drugs/TRIPS PLUS issue

Page 12: Feedback received from partners

12

Partner inputs on key issues (Summary)

Advocacy & Research

 Strengthen advocacy efforts.

Ensure M & E system is negotiated with key constituencies in the country.

Page 13: Feedback received from partners

13

Partner inputs on key issues (Summary)

GIPA  National GIPA strategy, involving PLWHA

and affected communities at the NACO and SACS levels.

Involve PLWHA, and marginalized communities, use their experiences in NACP-III planning.

Page 14: Feedback received from partners

14

Partner inputs on key issues (Summary)

GIPA Specific budget allocations for national, state

and district level PLWHA networks.

    Concrete steps to decrease stigma and discrimination.

Treatment education for PLWHA.

Positive prevention through safer sex and safer injecting practices.

Page 15: Feedback received from partners

15

Role/Contribution towards NACP – III as envisaged by partners

WHO-WR: Provide technical guidance and advice in

care and treatment, ART, VCT, M & E, Training.

Projection of HIV/AIDS situation in India. Technical and managerial support to NACO.

Page 16: Feedback received from partners

16

Partner role/contribution towards NACP – III Contd.

World Bank Resource support for studies and

workshops

Support to GOI’s new National HIV/AIDS Strategic Plan.

Finance NACP-III activities other partners cannot finance.

Page 17: Feedback received from partners

17

Partner role/contribution towards NACP – III Contd.

DFID To pool funds along with other donors

for implementation of NACP-III. Fund studies to inform the

preparatory processes of NACP – III.

Page 18: Feedback received from partners

18

Partner role/contribution towards NACP – III Contd.

European Union Would fund research/studies on issues

proposed by/agreed with NACO & supported by UN Theme Group.

Continue financial support to GFATM, IAVI other regional and global initiatives & NGOs.

Page 19: Feedback received from partners

19

Partner role/contribution towards NACP – III Contd.

Bill & Melinda Gates Foundation Will commit $200 million over five years to

focused HIV/AIDS prevention efforts. Will concentrate on the 6 highest prevalent

states and national highways.

Page 20: Feedback received from partners

20

Partner role/contribution towards NACP – III Contd.

Bill & Melinda Gates Foundation Support initiatives in capacity building,

communications, research and impact measurement.

Creation of enabling environment, galvanizing political and societal leaders.

Page 21: Feedback received from partners

21

Partner role/contribution towards NACP – III Contd.

INP+ Work closely with NACO and SACS. Support advocacy,and service delivery. Giving a human voice and face to the

epidemic for people not directly touched by it.

Page 22: Feedback received from partners

22

Partner role/contribution towards NACP – III Contd.

INP+ Giving a human voice and face to the

epidemic for people not directly touched by it.

Running care models and building networks.

Page 23: Feedback received from partners

23

Partner role/contribution towards NACP – III Contd.

IAVI Facilitate efforts for preparation of a

national AIDS vaccine development plan. Provide technical expertise on AIDS

vaccine and clinical trials.

Page 24: Feedback received from partners

24

IAVI Facilitate epidemiological studies in

partnership with SACS. Share and help implement international

best practices related to vaccine, R&D activities.

Page 25: Feedback received from partners

THANK YOU